Literature DB >> 3306139

[Beta interferon therapy in hairy cell leukemia].

P von Wussow, J Dühlmann, T Grethlein, W D Hirschmann, E Hügl, O Koch, W R Martin, H W Pees, W Urbanitz, M Freund.   

Abstract

Eleven patients with histologically proven hairy-cell leukemia were treated for 2 to 6 months with a natural beta-interferon (beta-IFN) preparation (3 X 4 million units week i.v.). Three of the eight evaluable patients experienced a partial response, two a minor response, and three no improvement. A reduction of the hairy-cell infiltration of the bone marrow was observed in one patient. Typical IFN side-effects with flu-like symptoms were noted. These results demonstrate that IFN-beta has some clinical efficacy in hairy-cell leukemia.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3306139     DOI: 10.1007/BF01875507

Source DB:  PubMed          Journal:  Klin Wochenschr        ISSN: 0023-2173


  10 in total

1.  Primary treatment of hairy cell leukemia: should IFN-therapy replace splenectomy?

Authors:  F Porzsolt
Journal:  Blut       Date:  1986-05

2.  Treatment of hairy-cell leukaemia with recombinant human alpha 2-interferon.

Authors:  J T Janssen; B E de Pauw; R S Holdrinet
Journal:  Lancet       Date:  1984-05-05       Impact factor: 79.321

3.  Interferon kinetics and adverse reactions after intravenous, intramuscular, and subcutaneous injection.

Authors:  R J Wills; S Dennis; H E Spiegel; D M Gibson; P I Nadler
Journal:  Clin Pharmacol Ther       Date:  1984-05       Impact factor: 6.875

4.  Interferon: pharmacokinetics and toxicity.

Authors:  G M Scott
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  1982-09-24       Impact factor: 6.237

5.  Alpha interferon for induction of remission in hairy-cell leukemia.

Authors:  J R Quesada; J Reuben; J T Manning; E M Hersh; J U Gutterman
Journal:  N Engl J Med       Date:  1984-01-05       Impact factor: 91.245

6.  [Effectiveness of gamma interferon and alpha interferon in hairy cell leukemia].

Authors:  N Niederle; C Doberauer; O Kloke; K Höffken; C G Schmidt
Journal:  Klin Wochenschr       Date:  1987-07-15

7.  Treatment of hairy cell leukemia with recombinant alpha 2 interferon.

Authors:  M J Ratain; H M Golomb; J W Vardiman; E E Vokes; R H Jacobs; K Daly
Journal:  Blood       Date:  1985-03       Impact factor: 22.113

8.  Interferon is effective in hairy-cell leukaemia.

Authors:  C P Worman; D Catovsky; P C Bevan; L Camba; M Joyner; P J Green; H J Williams; J M Bottomley; E C Gordon-Smith; J C Cawley
Journal:  Br J Haematol       Date:  1985-08       Impact factor: 6.998

9.  Recombinant alpha-2-interferon for hairy cell leukemia.

Authors:  A D Jacobs; R E Champlin; D W Golde
Journal:  Blood       Date:  1985-04       Impact factor: 22.113

10.  Receptors for human alpha and beta interferon but not for gamma interferon are specified by human chromosome 21.

Authors:  A Raziuddin; F H Sarkar; R Dutkowski; L Shulman; F H Ruddle; S L Gupta
Journal:  Proc Natl Acad Sci U S A       Date:  1984-09       Impact factor: 11.205

  10 in total
  1 in total

1.  Divergent in vivo and in vitro antileukemic activity of recombinant interferon beta in patients with chronic-phase chronic myelogenous leukemia.

Authors:  W E Aulitzky; C Peschel; D Desprès; J Aman; P Trautman; H Tilg; G Rudolf; H Hüttmann; J Obermeier; M Herold
Journal:  Ann Hematol       Date:  1993-11       Impact factor: 3.673

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.